US 12241099
Peptide therapeutics for treating Alzheimer's disease and related conditions
granted A61KA61K38/00A61K38/482
Quick answer
US patent 12241099 (Peptide therapeutics for treating Alzheimer's disease and related conditions) held by The Board of Regents of the University of Oklahoma expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/00, A61K38/482, A61K38/486, A61P